Literature DB >> 24426200

Importance of Serum Copper and Vascular Endothelial Growth Factor (VEGF-A) Levels in Postmenopausal Bleeding.

Afshan Rafi1, Ramakrishna Devaki1, K Sabitha2, Shruti Mohanty1, Pragna Rao3.   

Abstract

The main aim of this study is association of serum copper and vascular endothelial growth factor (VEGF-A) in postmenopausal bleeding (PMB) patients. Blood samples were collected from female patients suffering with postmenopausal bleeding (n = 50) as well as healthy females as controls (n = 50). Serum copper levels were estimated by spectrophotometric method and serum VEGF-A by ELISA technique and compared with ultrasonographic measurement of endometrial thickness in both patients and controls. A significant increase in serum copper levels and an almost twofold increase in serum VEGF-A was observed in DUB patients when compared with controls. Correlation (r) between serum VEGF-A levels and endometrial thickness was 0.96. Odds ratio for copper, VEGF-A and combination of copper and VEGF-A was 0.0426, 0.0947 and 0.0313 respectively, in all these cases odds ratio was <1. The abnormal angiogenesis in PMB could be due to increased serum copper levels,which in turn stimulates factors like VEGF-A, thereby causing an increase in endometrial growth.

Entities:  

Keywords:  ELISA; Postmenopausal bleeding; Serum copper; VEGF-A; Vascular endothelial growth factor

Year:  2012        PMID: 24426200      PMCID: PMC3613505          DOI: 10.1007/s12291-012-0240-9

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  22 in total

1.  Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study.

Authors:  G J Brewer; R D Dick; D K Grover; V LeClaire; M Tseng; M Wicha; K Pienta; B G Redman; T Jahan; V K Sondak; M Strawderman; G LeCarpentier; S D Merajver
Journal:  Clin Cancer Res       Date:  2000-01       Impact factor: 12.531

Review 2.  Recent advances in endometrial angiogenesis research.

Authors:  Jane E Girling; Peter A W Rogers
Journal:  Angiogenesis       Date:  2005-10-07       Impact factor: 9.596

3.  Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma.

Authors:  Steven Brem; Stuart A Grossman; Kathryn A Carson; Pamela New; Surasak Phuphanich; Jane B Alavi; Tom Mikkelsen; Joy D Fisher
Journal:  Neuro Oncol       Date:  2005-07       Impact factor: 12.300

4.  Serum and endometrial sodium and potassium levels with inert and copper-containing IUCDs and relation to serum steroid levels.

Authors:  K Fahmy; M Ghoneim; I Eisa; A el-Gazar; A Afifi
Journal:  Contraception       Date:  1992-06       Impact factor: 3.375

5.  Endometrial cancer in patients undergoing diagnostic curettage.

Authors:  O Gemer; S Segal
Journal:  Arch Gynecol Obstet       Date:  1998       Impact factor: 2.344

6.  Copper-induced vascular endothelial growth factor expression and wound healing.

Authors:  Chandan K Sen; Savita Khanna; Mika Venojarvi; Prashant Trikha; E Christopher Ellison; Thomas K Hunt; Sashwati Roy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-05       Impact factor: 4.733

Review 7.  Diagnostic evaluation of the endometrium in postmenopausal bleeding: an evidence-based approach.

Authors:  N van Hanegem; M C Breijer; K S Khan; T J Clark; M P M Burger; B W J Mol; A Timmermans
Journal:  Maturitas       Date:  2010-12-08       Impact factor: 4.342

8.  Focal vascular endothelial growth factor correlates with angiogenesis in human endometrium. Role of intravascular neutrophils.

Authors:  C E Gargett; F Lederman; B Heryanto; L S Gambino; P A Rogers
Journal:  Hum Reprod       Date:  2001-06       Impact factor: 6.918

9.  The role of transvaginal ultrasound in the investigation of women with post-menopausal bleeding.

Authors:  M Briley; D R Lindsell
Journal:  Clin Radiol       Date:  1998-07       Impact factor: 2.350

10.  What is the recurrence rate of postmenopausal bleeding in women who have a thin endometrium during a first episode of postmenopausal bleeding?

Authors:  H C Van Doorn; A Timmermans; B C Opmeer; R F M P Kruitwagen; F P H L J Dijkhuizen; G S Kooi; P H M Van De Weijer; B W J Mol; For Dupomeb
Journal:  Acta Obstet Gynecol Scand       Date:  2008       Impact factor: 3.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.